<DOC>
	<DOCNO>NCT00729443</DOCNO>
	<brief_summary>The study carry order investigate safety , tolerability pharmacokinetics administrate single fractionate dos AZD3241 healthy volunteer</brief_summary>
	<brief_title>Investigating Safety , Tolerability Pharmakinetics When Giving Single Fractionated Doses AZD3241 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Provision inform consent Body Mass Index ( BMI ) 19 30 kg/m2 inclusive Clinically normal physical finding , include BP , pulse rate , ECG laboratory finding , judge investigator Clinically significant illness within 2 week prior administration investigational product Heart rate ( rest , recumbent ) &lt; 50 bmp &gt; 85 bmp History severe allergy/hypersensitivity ongoing allergy/hypersensitivity judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Single dose</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Safety AZD3241</keyword>
	<keyword>tolerability AZD3241</keyword>
</DOC>